Skip to Main Content


Skip Nav Destination

Antitumor Efficacy of the Novel KIT Inhibitor IDRX-42 (Formerly M4205) in Patient- and Cell Line–Derived Xenograft Models of Gastrointestinal Stromal Tumor (GIST)

Clin Cancer Res (2023) 29 (15): 2859–2868.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
  • Carlo María Cicala
  • Iván Olivares-Rivas
  • Jon Ander Aguirre-Carrillo
  • César Serrano
Expert Opinion on Investigational Drugs (2024) 33 (3): 159.
Close Modal

or Create an Account

Close Modal
Close Modal